New update from the International Severe Asthma Registry (ISAR)!

puiyeelai
3 days ago
1 min read

New real-world insights from the International Severe Asthma Registry (ISAR), spanning data from over 25 countries, have been featured in The Medical Independent. This global collaboration sheds light on treatment patterns, clinical outcomes, and unmet needs in severe asthma care, aiming to improve patient management and inform future research.

Recent Posts

See All

Biologics for asthma prevent new-onset diabetes, major adverse cardiovascular events (MACE) as well as other oral corticosteroid (OCS)-related adverse events: Ground-breaking results from SOLAR II

Switching or stopping biologic therapy was associated with worse clinical outcomes than continuing the initial therapy: Results from CLEAR

Global disease burden of patients with severe asthma, regardless of biologic accessibility and receipt of biologic treatment: Results from EVEREST

Comments